NIH-funded research R21 grant

Investigating immune responses in a fruit fly model of frontotemporal dementia

Official title: Mechanistic Investigation of Innate Immunity in a Drosophila Model of Frontotemporal Dementia

Funded at Univ of Massachusetts Med Sch Worcester · NIH-10903318 · Data updated 2026-11-12

This study is looking at how certain natural defenses in fruit flies might help us understand frontotemporal dementia and ALS better, especially how a specific protein could protect against the damage caused by harmful proteins, which could lead to new treatment ideas for people with these conditions.

More Dementia research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester
NIH-funded
Lab location1 site (Worcester, United States)
Project startApril 15, 2024
Project endMarch 31, 2026
Funding year2024
Award (this year)$460,625
NIH project number1R21AG085108-01A1
Project IDNIH-10903318 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with frontotemporal dementia or amyotrophic lateral sclerosis, particularly those with genetic links to the C9ORF72 gene.

Less likely to help

Patients with other forms of dementia or neurodegenerative diseases not related to FTD or ALS may not benefit from this research.

What this research studies

This research explores the mechanisms of innate immunity in a fruit fly model to understand frontotemporal dementia (FTD) and its connection to amyotrophic lateral sclerosis (ALS). The study focuses on the role of specific antimicrobial peptides, particularly metchnikowin, in mitigating neurodegeneration caused by toxic proteins associated with these diseases. By examining how these peptides interact with neurotoxic elements at a molecular level, the research aims to uncover new pathways that could lead to potential therapeutic targets for FTD and ALS. Patients may benefit from insights gained that could inform future treatments for these conditions.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating frontotemporal dementia and ALS.

How similar studies have gone: While the specific approach in this research is novel, there have been successful studies investigating immune responses in neurodegenerative diseases, suggesting potential for impactful findings.

Where this research is happening

  • Univ of Massachusetts Med Sch Worcester
    Worcester, United States
    Active

Researchers

  • Principal investigator: Gao, Fen-Biao — Univ of Massachusetts Med Sch Worcester
  • Study coordinator: Gao, Fen-Biao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.